Programme : Back to Dr Nathalie MAUBON

Development of neuroprotection model for Parkinson disease using High Content Screening


Parkinson's disease (PD), a neurodegenerative disorder, is caused by the death of dopaminergic neurons in the substantia nigra. High content screening (HCS) should allow finding new pathways involved in the onset of PD by screening molecules based on phenotypes related to cell death. Rotenone, a chemical compound commonly used as a pesticide, is well-documented as a cell death inducer of dopaminergic neurons in the substantia nigra and allows mimicking PD in vitro and in vivo.
HCS Pharma is working to develop new, more complex and relevant in vitro cellular models that mimic the pathology as closely as possible. In this poster, a neuroprotection model of PD is presented, with differenciated SH-SY5Y neuronal cells, exposed to rotenone. Model was developed in 2D culture and first results in 3D culture are also presented.
Add to favourites

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018